TIPA Successfully Concludes 'Korea-China Bio Technology Commercialization Conference'

Policy Measures to Foster a Technology Cooperation Ecosystem Between Korean and Chinese SMEs in the Bio Sector

Jang Hyun-sung, Head of the TIPA Cooperation Business Division, is delivering a congratulatory speech at the "Korea-China Bio Technology Commercialization Conference" on the 23rd.
[Photo by TIPA]

[Asia Economy Reporter Kim Jong-hwa] The "Korea-China Bio Technology Commercialization Conference," organized by the Korea Technology and Information Promotion Agency for SMEs (TIPA) in collaboration with the KAIST Global Commercialization Center (GCC) and Jiangsu Science and Technology Department (JSTD) of China, was successfully concluded on the 23rd at the SupEX Hall of KAIST Munji Campus.

The Korea-China Bio Technology Commercialization Conference was established to support domestic bio-sector small and venture companies in seeking cooperative relationships with Chinese companies and advancing into the Chinese market to become global enterprises amid the rapid growth of the biohealth industry due to the global pandemic situation.

Local related organizations participated, including the Jiangsu Science and Technology Department, the Yangtze River Delta National Technology Innovation Center, Jiangsu International Technology Transfer Center, Shandong Yantai High-tech Industrial Development Zone, and the Korea-China Industrial Technology Innovation Research Institute, all located in Jiangsu Province, which has a global-scale bioindustry.

Professor Han Byung-hwan of Daejeon University, who presented at the conference, delivered presentations on △Trends in the Korean bio industry, △Status of Korean bio companies, and △Government support policies for the bio industry and companies. Zhu Biwin, Director of Social Development and Basic Research at the Jiangsu Science and Technology Department, introduced △The bio industry and company status in Jiangsu Province and △Government and Jiangsu Province support policies for the bio industry and companies in China.

Subsequently, seven bio-sector experts from Korea and China discussed detailed issues in the bio industries of both countries and deliberated on specific measures to create a global cooperation ecosystem among bio-sector small and venture companies, including expanding exchanges between national bio clusters led by governments alongside corporate cooperation.

In particular, based on the strong commitment of both governments to foster the bio industry and the active investment and research and development (R&D) by companies at the private level, they agreed on the need for mutual active networking and collaboration to expand each country's influence in the global bio market currently dominated by advanced countries.

In the company-specific technology presentation session, a total of 20 companies from both countries participated, introducing core technologies in key fields such as pharmaceuticals, medical devices, and diagnostic equipment. Following this, an online business meeting was held for pre-matched Korean and Chinese bio-sector companies to discuss specific matters related to technology cooperation and technology commercialization.

Jang Hyun-sung, Head of the Cooperation Business Division at TIPA, said, "I hope this served as a good opportunity to promote technology cooperation with Chinese companies as part of our efforts for our small and venture companies to lead future high value-added industries," adding, "We will continue to work closely with related organizations including the GCC to do our best in overseas technology commercialization and building a global technology cooperation ecosystem for our small and venture companies."

This content was produced with the assistance of AI translation services.